You searched for "clinic"

2022 results found

A safe management pathway for low-risk head and neck cancer suspected referrals

Head and neck cancer is the eighth most common malignancy and numbers are increasing. This has led to increasing number of suspected cancer referrals which, with imposition of the 28-day Faster Diagnosis Standard implemented in 2020, has further burdened the...

House of Hearing expands with the relocation of two Scottish clinics

House of Hearing is pleased to announce the relocation of their St Andrews and Perth clinics on the 30th May and 27th June 2022, respectively.

Retrospective review of paediatric salivary gland tumours

As is the case with adults, primary tumours of the salivary glands in children comprise a heterogeneous collection of different histological types. This paper presents a retrospective review of primary salivary gland tumours in children treated over the course of...

ENT and audiology in the Land of a Thousand Hills

Rwanda is a beautiful country known as the ‘Land of a Thousand Hills’. It is located in the Great Rift Valley in East Africa and shares borders with Uganda, Tanzania, Burundi, and the Democratic Republic of Congo, all offering direct...

Paediatric salivary gland tumours

This is a review article of a rare group of neoplasms that frequently present as painless preauricular mass in older children. There is a wide differential including first branchial arch abnormalities, inflammatory and granulomatous processes. Those masses that are painless,...

Lenire®, the tinnitus treatment device, now available in Norway

Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.

Neuromod expands availability of Lenire tinnitus treatment device in Europe with 19 new clinical partnerships

Neuromod Devices, the technology company that specialises in medical devices for tinnitus treatment, has announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe. This latest expansion will significantly increase the number of...

Breakthrough tinnitus device Lenire available in three new clinics in Spain

Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.

Hearables: in-ear sensing devices for recording of physiological signals

Colver Ken Howe Ne, Jameel Muzaffar and Manohar Bance discuss the potential of hearable systems to monitor physiological signals (e.g. from brain or heart, blood pressure, body temperature) unobtrusively. Such adaptations require high-quality sensors and sophisticated de-noising signal processing on...

A time-saving method for faster cancer diagnosis and treatment

One of the main impediments in achieving UK Government cancer diagnosis and treatment targets is lack of diagnostic capacity. An increase in head and neck cancers by 50% in the last five years has put on additional strain. In this...

UK clinics providing Lenire tinnitus treatment device double in latest expansion

Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...

Effective and profitable provision of paediatric audiology care in the private sector

Similar to other specialty areas of hearing healthcare, paediatric audiology is a potential net loss for a private-sector, for-profit, business. Given the time-intensive needs of patients with cochlear implants, tinnitus and those who are under the age of 18 years...